@article{GPM4793,
author = {Taek-Sang Lee},
title = {Combined chemoradiation in high-risk endometrial cancer: benefit or not?},
journal = {Gynecology and Pelvic Medicine},
volume = {1},
number = {0},
year = {2018},
keywords = {},
abstract = {Recently, the final results of the large scaled randomized intergroup trial named PORTEC-3 was released showing that adjuvant chemotherapy given concurrently during and after pelvic irradiation in women with high-risk endometrial carcinoma provided no significant 5-year failure-free (FFS) or overall survival (OS) benefit, compared with radiotherapy (RT) alone (1).},
issn = {2617-4499}, url = {https://gpm.amegroups.org/article/view/4793}
}